Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
Phase 4
Completed
- Conditions
- Secondary HyperparathyroidismChronic Kidney Disease
- Registration Number
- NCT00073710
- Lead Sponsor
- Abbott
- Brief Summary
A study to investigate the effects of Zemplar and Calcijex on intestinal calcium absorption in hemodialysis subjects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method The mean within subject difference in calcium absorption rates between treatment regimens will be analyzed using ANOVA appropriate for a two-period cross-over trial.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Creighton University
🇺🇸Omaha, Nebraska, United States